D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 16 710 KRW 2.26% Market Closed
Market Cap: 734.6B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Dongkook Pharmaceutical Co Ltd
Investor Relations

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Heung-Ju Oh
CEO, VP & Director
No Bio Available
Mr. Young-Wook Lee
CEO, Pres & Director
No Bio Available
Mr. Hong-Ki Kim
Director of Fin.
No Bio Available
Mr. Gyu-Jin Lee
Managing Director of Factory Management
No Bio Available
Mr. Joon-Ho Song
Sr. Managing Director of Strategic Planning
No Bio Available
Mr. Soon-Kang Hong
Sr. Managing Director of PR
No Bio Available
Mr. Hee-Soon Park
Sr. Managing Director of Marketing
No Bio Available
Mr. Je-Won Park
Sr. Managing Director of Sales
No Bio Available

Contacts

Address
SEOUL
Seoul
Dongkook Bldg., 7, Teheran-ro 108-gil, Gangnam-gu
Contacts
+82221919800
www.dkpharm.co.kr